US Patent Issued to UNIVERSITY OF SOUTHAMPTON on Jan. 20 for "Combined use of Fc gamma RIIb (CD32B) and CD20 specific antibodies" (British, Swedish Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,866, issued on Jan. 20, was assigned to UNIVERSITY OF SOUTHAMPTON (Southampton, Great Britain).

"Combined use of Fc gamma RIIb (CD32B) and CD20 specific antibodies" was invented by Mark Cragg (Southampton, Great Britain), Martin Glennie (Southampton, Great Britain), Ali Roghanian (Southampton, Great Britain), Stephen Beers (Southampton, Great Britain), Peter Johnson (Southampton, Great Britain), Sean Lim (Southampton, Great Britain), Bjorn Frendeus (Landskrona, Sweden) and Ingrid Teige (Lund, Sweden).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides a method of treating a patient having target cells that express FcGammaRIIb, the m...